2013 Fiscal Year Final Research Report
Comprehensive analysis of IGF2 DMR0 methylation level in esophageal cancer
Project/Area Number |
24659617
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Single-year Grants |
Research Field |
Digestive surgery
|
Research Institution | Kumamoto University |
Principal Investigator |
BABA Yoshifumi 熊本大学, 大学院生命科学研究部, 講師 (20599708)
|
Co-Investigator(Kenkyū-buntansha) |
SAKAMOTO Yasuo 熊本大学, 医学部附属病院, 特任助教 (00452897)
ISHIMOTO Takatsugu 熊本大学, 大学院生命科学研究部, 特任助教 (00594889)
IWAGAMI Shiro 熊本大学, 医学部附属病院, 特任助教 (70530153)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Keywords | 癌 / トランスレーショナルリサーチ / IGF2 DMR0 / メチル化 |
Research Abstract |
The methylation level at IGF2 DMR0 is correlated with IGF2 LOI and is a suggested surrogate marker for IGF2 LOI.The IGF2 imprinting status was screened using ApaI polymorphism, and IGF2 protein expression was evaluated by immunohistochemistry with 30 esophageal squamous cell carcinoma tissue specimens. For survival analysis, IGF2 DMR0 methylation was measured using a bisulfite pyrosequencing assay with 216 ESCC tissue specimens. IGF2 LOI cases exhibited lower DMR0 methylation levels than IGF2 non-LOI cases. Among 202 patients eligible for survival analysis,IGF2 DMR0 hypomethylation was significantly associated with higher cancer-specific mortality. The IGF2 DMR0 methylation level in ESCC was associated with IGF2 LOI and IGF2 protein expression.In addition, IGF2 DMR0 hypomethylation was associated with a shorter survival time, suggesting its potential role as a prognostic biomarker.
|
-
[Journal Article] IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma2014
Author(s)
Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, Morita M, Nakao M, Baba H
-
Journal Title
Ann Surg Oncol
Volume: 21(4)
Pages: 1166-74
DOI
Peer Reviewed
-
[Journal Article] LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma2014
Author(s)
Baba Y, Watanabe M, Murata A, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Yoshida N, Oki E, Sakamaki K, Nakao M, Baba H
-
Journal Title
Clin Cancer Res
Volume: 20(5)
Pages: 1114-24
DOI
Peer Reviewed
-
-
-
[Journal Article] Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer2013
Author(s)
Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ishimoto T, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Nosho K, Baba H
-
Journal Title
Br J Cancer
Volume: 109(2)
Pages: 408-15
DOI
Peer Reviewed
-
[Journal Article] LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis2013
Author(s)
Shigaki H, Baba Y, Watanabe M, Murata A, Iwagami S, Miyake K, Ishimoto T, Iwatsuki M, Baba H
-
Journal Title
Gastric Cancer
Volume: 16(4)
Pages: 480-7
DOI
Peer Reviewed
-
[Journal Article] Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer2013
Author(s)
Suzuki M, Shiraishi K, Eguchi A, Ikeda K, Mori T, Yoshimoto K, Ohba Y, Yamada T, Ito T, Baba Y, Baba H
-
Journal Title
Oncol Rep
Volume: 29(4)
Pages: 1308-14
DOI
Peer Reviewed
-
[Journal Article] Pyrosequencing Assay to Measure LINE-1 Methylation Level in Esophageal Squamous Cell Carcinoma2012
Author(s)
Iwagami S, Baba Y, Watanabe M, Shigaki H, Miyake K, Ida S, Nagai Y, Ishomoto T, IIwatsuki M, Sakamoto Y, Miyamoto Y, Baba H
-
Journal Title
Annals of Surgical Oncology
Volume: 19(8)
Pages: 2726-32
DOI
Peer Reviewed
-
-
-
-
-
-
-
-
[Presentation] Relationship between LINE-1 methylation level, allelic imbalance and PIK3CA mutation in esophageal squamous cell carcinoma2013
Author(s)
Baba Y, Watanabe M, Murata A, Shigaki H, Iwagami S, Iwatsuki M, Ishimoto T, Baba H
Organizer
AACR Annual Meeting 2013
Place of Presentation
Washington, DC, USA
Year and Date
2013-04-09
-
-
[Presentation] Hypomethylation of the IGF2 DMR0 in Esophageal Squamous Cell Carcinoma, Detected by Bisulfite Pyrosequencing, is Associated with Poor Prognosis2013
Author(s)
Murata A, Baba Y, Watanabe M, Shigaki H, Miyake K, Ozaki N, Ishimoto T, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Baba H
Organizer
9th AACR-Japanese Cancer Association Joint Conference (AACR-JCA)
Place of Presentation
Hyatt Regency Maui, Hawaii
Year and Date
2013-02-23
-